Skip to main content
. Author manuscript; available in PMC: 2017 Jan 27.
Published in final edited form as: Cell Rep. 2017 Jan 17;18(3):804–815. doi: 10.1016/j.celrep.2016.12.068

Figure 5.

Figure 5

Receptor tyrosine kinase inhibitors block infection only in cells that express high levels of the entry factor AXL. (A) The indicated cell lines were processed for immunoblot for AXL and the control tubulin. A representative experiment is shown. U2OS (B) or HBMEC (C) cells were treated with the indicated drugs and infected with ZIKV (Mex2-81, MOI=2.5) and processed for RT-qPCR analysis to monitor the level of infection from 3 independent experiments with mean±SD shown. (D–F) The indicated cell type was treated with the indicated drugs and infected with ZIKV (Mex2-81) and TCID50s were calculated for 3 independent experiments with mean±SD shown. *p,0.05.